| Charles Nephi Webb, MD | |
|
1000 N Curtis Rd, Ste 303, Boise, ID 83706-1347 | |
| (208) 377-4000 | |
| (208) 375-8426 |
| Full Name | Charles Nephi Webb |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 29 Years |
| Location | 1000 N Curtis Rd, Boise, Idaho |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609865880 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207KA0200X | Allergy & Immunology - Allergy | M-7118 (Idaho) | Primary |
| 208000000X | Pediatrics | M-7118 (Idaho) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Luke's Regional Medical Center | Boise, ID | Hospital |
| St Luke's Nampa Medical Center | Nampa, ID | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Allergy Group Pc | 5799747317 | 6 |
News Archive
Can a cozy dining table and nice music prompt people to reach for the greens and go light on dessert? So suggests a new study probing why people tend to eat more-nutritious meals at home than away from home. The findings, based on data from 160 women who reported their emotional states before and after meals, add to mounting evidence that psychological factors may help override humans' wired-in preference for high-fat, sugary foods.
Insurance companies are banding together to weaken a key health law rule that requires them to spend as much as 85 percent of their revenues on medical care, according to the advocacy group Health Care for America Now. At issue is the definition of 'medical loss ratio,' a figure used on Wall Street to show an insurer's profitability.
News outlets report on the work ahead regarding this budget-trimming panel. First on the list — appointing its members. After that, however, the hard work of finding at least $1.2 trillion in spending cuts will begin.
Researchers have discovered a chemical that specifically blocks people's ability to detect the bitter aftertaste that comes with artificial sweeteners such as saccharin. The key is a molecule known only as GIV3727 that specifically targets and inhibits a handful of human bitter taste receptors, according to a report published online on May 27th in Current Biology, a Cell Press publication.
Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.
› Verified 8 days ago
| Entity Name | Allergy Group Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316979974 PECOS PAC ID: 5799747317 Enrollment ID: O20041027000279 |
News Archive
Can a cozy dining table and nice music prompt people to reach for the greens and go light on dessert? So suggests a new study probing why people tend to eat more-nutritious meals at home than away from home. The findings, based on data from 160 women who reported their emotional states before and after meals, add to mounting evidence that psychological factors may help override humans' wired-in preference for high-fat, sugary foods.
Insurance companies are banding together to weaken a key health law rule that requires them to spend as much as 85 percent of their revenues on medical care, according to the advocacy group Health Care for America Now. At issue is the definition of 'medical loss ratio,' a figure used on Wall Street to show an insurer's profitability.
News outlets report on the work ahead regarding this budget-trimming panel. First on the list — appointing its members. After that, however, the hard work of finding at least $1.2 trillion in spending cuts will begin.
Researchers have discovered a chemical that specifically blocks people's ability to detect the bitter aftertaste that comes with artificial sweeteners such as saccharin. The key is a molecule known only as GIV3727 that specifically targets and inhibits a handful of human bitter taste receptors, according to a report published online on May 27th in Current Biology, a Cell Press publication.
Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Charles Nephi Webb, MD 1000 N Curtis Rd, Ste 303, Boise, ID 83706-1347 Ph: (208) 828-7297 | Charles Nephi Webb, MD 1000 N Curtis Rd, Ste 303, Boise, ID 83706-1347 Ph: (208) 377-4000 |
News Archive
Can a cozy dining table and nice music prompt people to reach for the greens and go light on dessert? So suggests a new study probing why people tend to eat more-nutritious meals at home than away from home. The findings, based on data from 160 women who reported their emotional states before and after meals, add to mounting evidence that psychological factors may help override humans' wired-in preference for high-fat, sugary foods.
Insurance companies are banding together to weaken a key health law rule that requires them to spend as much as 85 percent of their revenues on medical care, according to the advocacy group Health Care for America Now. At issue is the definition of 'medical loss ratio,' a figure used on Wall Street to show an insurer's profitability.
News outlets report on the work ahead regarding this budget-trimming panel. First on the list — appointing its members. After that, however, the hard work of finding at least $1.2 trillion in spending cuts will begin.
Researchers have discovered a chemical that specifically blocks people's ability to detect the bitter aftertaste that comes with artificial sweeteners such as saccharin. The key is a molecule known only as GIV3727 that specifically targets and inhibits a handful of human bitter taste receptors, according to a report published online on May 27th in Current Biology, a Cell Press publication.
Cipher Pharmaceuticals Inc. today announced it has strengthened its Canadian dermatology portfolio by acquiring the Canadian rights to Vaniqa and Actikerall from Almirall S. A., a Spanish pharmaceutical company. Both products have been approved by Health Canada.
› Verified 8 days ago
George William Palmer, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Ste 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 | |
John D Jeppson, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Suite 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 | |
Michael V Keiley, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 901 N Curtis Rd, Ste 100, Boise, ID 83706 Phone: 208-378-0080 Fax: 208-378-0259 |